Pluristem Therapeutics Profit Margin 2006-2021 | PSTI
Current and historical gross margin, operating margin and net profit margin for Pluristem Therapeutics (PSTI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Pluristem Therapeutics net profit margin as of September 30, 2021 is 0%.
|Pluristem Therapeutics Annual Profit Margins
|Pluristem Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
PLURISTEM THERAPEUTICS INC. is a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. The Company is developing a pipeline of products, stored ready-to-use, that are derived from the human placenta, a non-controversial source, and not from embryonic stem cells.